The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus

  • Luke D. Jasenosky
  • , Cristhian Cadena
  • , Chad E. Mire
  • , Viktoriya Borisevich
  • , Viraga Haridas
  • , Shahin Ranjbar
  • , Aya Nambu
  • , Sina Bavari
  • , Veronica Soloveva
  • , Supriya Sadukhan
  • , Gail H. Cassell
  • , Thomas W. Geisbert
  • , Sun Hur
  • , Anne E. Goldfeld

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology